Sánchez Juliana, Villada Oscar Alonso, Rojas Maylen Liseth, Montoya Liliana, Díaz Alejandro, Vargas Cristian, Chica Javier, Herrera An A Milena
Grupo de Investigación Ciencias Básicas, Facultad de Medicina, Universidad CES, Medellín, Colombia.
Dirección de Investigación, Facultad de Medicina, Universidad CES, Medellín, Colombia.
Biomedica. 2014 Jan-Mar;34(1):79-91. doi: 10.1590/S0120-41572014000100011.
Zinc deficiency is common in children among populations in developing areas. Zinc deficiency alters the immune system and the resistance to infections.
To evaluate the effect of two zinc compounds in the prevention of acute respiratory infection and acute diarrhea.
Randomized triple-blind community trial with 301 children between 2-5 years of age from six child daycare centers in Medellin, Colombia. Children were distributed in three groups receiving zinc amino acid chelate, zinc sulfate and placebo five days a week for 16 weeks. Daily symptoms of respiratory infection, acute diarrhea and side effects were evaluated.
The incidence of respiratory infection was lower with zinc amino acid chelate (1.42 per 1,000 child-days) compared with placebo (3.3 per 1,000 child-days) (RR=0.43, 95% CI: 0.196 to 0.950, p=0.049) and with zinc sulfate (1.57 per 1,000 child-days) (RR=0.90, 95% CI 0.382 to 2.153, p=0.999). The incidence of acute diarrhea with zinc amino acid chelate (0.15 per 1,000 child-days) was lower than with placebo (0.49 per 1,000 child-days) (RR=0.32, 95% CI 0.006 to 3.990, p=0.346) and with zinc sulfate (0.78 per 1,000 child-days) (RR=0.20, 95% CI: 0.0043 to 1.662, p=0.361).
Zinc amino acid chelate had a better effect in reducing the incidence of acute respiratory infection and acute diarrhea in preschool children when compared with the other groups.
锌缺乏在发展中地区人群的儿童中很常见。锌缺乏会改变免疫系统和抗感染能力。
评估两种锌化合物在预防急性呼吸道感染和急性腹泻方面的效果。
对来自哥伦比亚麦德林六个儿童日托中心的301名2至5岁儿童进行随机三盲社区试验。儿童被分为三组,每周五天接受氨基酸螯合锌、硫酸锌和安慰剂,持续16周。评估呼吸道感染、急性腹泻的每日症状及副作用。
与安慰剂组(每1000儿童日3.3例)相比,氨基酸螯合锌组呼吸道感染发生率较低(每1000儿童日1.42例)(相对危险度=0.43,95%可信区间:0.196至0.950,p=0.049),与硫酸锌组(每1000儿童日1.57例)相比也是如此(相对危险度=0.90,95%可信区间0.382至2.153,p=0.999)。氨基酸螯合锌组急性腹泻发生率(每1000儿童日0.15例)低于安慰剂组(每1000儿童日0.49例)(相对危险度=0.32,95%可信区间0.006至3.990,p=0.346),与硫酸锌组(每1000儿童日0.78例)相比也是如此(相对危险度=0.20,95%可信区间:0.0043至?[此处原文有误,推测应为1.662],p=0.361)。
与其他组相比,氨基酸螯合锌在降低学龄前儿童急性呼吸道感染和急性腹泻发生率方面效果更好。